Pharmafile Logo
Pharmafocus logo
Advanced Search

VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial

April 13, 2022
Research and Development

VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …

News

NICE recommends avelumab for urothelial cancer patients

April 13, 2022
Research and Development

NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …

News

FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall

April 13, 2022
Research and Development

The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …

News

It could take up to six years to clear the patient backlog in Europe

April 13, 2022
Research and Development

Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …

News

Tjaopack announces completion of Netherlands facility expansion

April 12, 2022
Manufacturing and Production

Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …

News

Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs

April 12, 2022
Manufacturing and Production

NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …

News

VR solution for personalised treatment and surgery guidance to spine surgeons

April 12, 2022
Manufacturing and Production

Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …

News
nhs_sign

SMC accepts Inrebic for treatment of splenomegaly and myelofibrosis

April 12, 2022

The SMC has accepted Inrebic (fedratinib) for use witin NHS Scotland, for the treatment of disease-related splenomegaly (enlarged spleen). It …

News

Recipharm announces closing of acquisitions of two major CDMOs

April 11, 2022
Sales and Marketing

Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …

News

Innovative therapy ‘tricks’ and destroys cancer cells

April 11, 2022
Sales and Marketing

A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …

News

World leaders pledge $4.8 billion in 2022 Break COVID Now Summit

April 11, 2022
Sales and Marketing

World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …

News

‘Killer’ immunotherapy shows early promise

April 11, 2022
Sales and Marketing

A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …

News

NICE publishes guidance for atopic dermatitis treatments

April 8, 2022
Medical Communications

Abrocitinib, upadacitinib, and tralokinumab are not recommended for treating moderate to severe atopic dermatitis. The recommendation does not affect patients …

News

First-of-its-kind vaccine manufacturing facility shipped to Africa

April 8, 2022
Medical Communications

KeyPlants announced the shipping a first-of-its-kind vaccine manufacturing filling facility to Senegal, in West Africa.

News

Acadia seeks first-ever FDA approval in Rett Syndrome

April 8, 2022
Medical Communications

Acadia has presented an update on its Phase III LAVENDER study of trofinetide for Rett Syndrome at the American Academy …

News

NIH funds tuberculosis research advancement centres

April 8, 2022
Medical Communications

News

Kintor’s antiviral shows protection in mild-to-moderate COVID-19

April 7, 2022
Business Services

Kintor Pharmaceutical, based in Suzhou, China, has announced top-line results from its Phase III MRCT trial of proxalutamide in outpatients …

News

Blood clot risk higher for six months after having COVID-19

April 7, 2022
Business Services

A study from Sweden suggests that after a COVID-19 infection, there is an increased risk of developing a serious blood …

News

Eligible patients in the UK granted early access for radioligand therapy in advanced prostate cancer

April 7, 2022
Business Services

Advanced Accelerator Applications (AAA), a Novartis company, has announced that eligible patients in the UK have been granted early access …

News

Global Paediatric Drug Development Centre of Excellence opened in Dublin’s North Dock

April 7, 2022
Business Services

Gilead Sciences announced on April 6th the formal opening of its Dublin city centre office, focused on developing new paediatric …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025